<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig5">
 <label>Fig. 5</label>
 <caption>
  <title>Antiviral potency of boceprevir (28), calpain inhibitors II (61), XII (62), and GC-376 (64), in CPE and VYR assays.</title>
  <p>
   <bold>a</bold>–
   <bold>d</bold> Primary CPE assay results of boceprevir (
   <bold>28</bold>), calpain inhibitors II (
   <bold>61</bold>), XII (
   <bold>62</bold>), and GC-376 (
   <bold>64</bold>). 
   <bold>e</bold>–
   <bold>h</bold> Secondary VYR assay results of boceprevir (
   <bold>28</bold>), calpain inhibitors II (
   <bold>61</bold>), XII (
   <bold>62</bold>), and GC-376 (
   <bold>64</bold>). Each dot represents the average of three repeats from one experiment, and each assay was repeated in three different experiments. The curve fittings were shown in Supplementary information, Fig. 
   <xref rid="MOESM2" ref-type="media">S2</xref>.
  </p>
 </caption>
 <graphic xlink:href="41422_2020_356_Fig5_HTML" id="d30e1620" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
